Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.11 USD
Change Today +0.18 / 1.51%
Volume 561.0K
VNDA On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

H. Thomas Watkins

Chairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee,Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 123 board members in 5 different organizations across 5 different industries.

See Board Relationships


Mr. H. Thomas Watkins, also known as Tom served as the Chief Executive Officer and President of Human Genome Sciences Inc., from November 22, 2004 to August 2012. Mr. Watkins has over 20 years of experience at Abbott Laboratories and its affiliates in the U.S. and Asia. He served as the President of TAP Pharmaceutical Products Inc. from September 1998 to August 2004, which is jointly owned by Abbott Laboratories and Takeda Pharmaceutical Company Limited. He joined Abbott ...

Read Full Background

Corporate Headquarters*

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships*

Chairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Transaction Committee


Bachelor's Degree
College of William & Mary
The University of Chicago Booth School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options113,749
Unexercisable Options6,251
Total Number of Options120,000

Total Compensation*

Total Annual Cash Compensation$60,401
Total Calculated Compensation$150,401
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $12.11 USD +0.18


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Olivier Brandicourt Chief Executive Officer and Director
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at